Question 1

Does Morgan Stanley own AKBA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Morgan Stanley holds 701,540 shares of AKBA (Akebia Therapeutics), worth $799,756.

Question 2

How many shares of AKBA does Morgan Stanley own?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley holds 701,540 shares of AKBA (Akebia Therapeutics).

Question 3

What is Morgan Stanley's AKBA position worth?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley's AKBA position is worth $799,756.

Question 4

Is Morgan Stanley buying or selling AKBA?

Accepted Answer

In Q2 2026, Morgan Stanley increased its AKBA position by 120,213 shares (+20.7%).

Question 5

When did Morgan Stanley first buy AKBA?

Accepted Answer

Morgan Stanley already held AKBA in its Q2 2024 13F, the earliest on record, and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	701,540	+20.7%	$799,756	0.0%	$1.14	20
2026-Q1	Decreased	581,327	-52.7%	$808,044	0.0%	$1.22	0
2025-Q4	Decreased	1.2M	-71.5%	$2M	0.0%	$1.59	0
2025-Q3	Decreased	4.3M	-19.2%	$11.8M	0.0%	$2.71	0
2025-Q2	Increased	5.3M	+99.2%	$19.4M	0.0%	$3.65	46
2025-Q1	Increased	2.7M	+49.8%	$5.1M	0.0%	$1.91	37
2024-Q4	Increased	1.8M	+64.4%	$3.4M	0.0%	$1.85	39
2024-Q3	Increased	1.1M	+42.6%	$1.4M	0.0%	$1.33	34
2024-Q2	First report	763,332	-	$778,599	0.0%	$1.02	0

AKBA9 quarters

AKBA
9 quarters